Results from a phase 2a study of trastuzumab emtansine, paclitaxel, and pertuzumab in patients with HER2-positive metastatic breast cancer Meeting Abstract


Authors: Elias, A.; Modi, S.; Krop, I. E.; Pegram, M.; Ipe, D.; Guardino, E. A.; Althaus, B.; LoRusso, P. L.
Abstract Title: Results from a phase 2a study of trastuzumab emtansine, paclitaxel, and pertuzumab in patients with HER2-positive metastatic breast cancer
Meeting Title: 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 73
Issue: 24 Suppl.
Meeting Dates: 2013 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-12-15
Language: English
ACCESSION: WOS:000209496902016
DOI: 10.1158/0008-5472.sabcs13-p4-12-09
PROVIDER: wos
Notes: Meeting Abstract: P4-12-09 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi